🦊/Investors

Fonds de solidarité FTQFull Portfolio

24 tracked investments · listed companies and verified rows first

Airex Energyairex-energy.comin✓ verified

Airex Energy develops torrefaction and carbonization systems that convert biomass residues into biocoal and biocarbon for industrial applications requiring renewable fuel and heat sources.

Circular EconomyCleantechClimate TechEnergy

Guy Prud'homme(Co-Founder and Chief Technology Officer)Michel Gagnon(Chief Executive Officer)

Co-investorsCycle Capital

Qohashqohash.comin𝕏✓ verified

Qohash provides a data security platform that discovers, classifies, and remediates sensitive unstructured data in place using a "zero copy" architecture that enforces security where the data lives rather than moving it.

CybersecurityData & InfrastructureEnterprise SoftwareQuébec City, CA

Co-investorsFINTOP CapitalDigital Currency GroupPanache Ventures

Theodorustheodorus.bein✓ verified

Theodorus is a Belgian seed-stage venture capital firm that invests in and supports researchers and entrepreneurs building science-based companies.

BiotechDeep Tech

Co-investorsFinance.BrusselsSambrinvestSofinaTeralys CapitalSeido Capital

Thryvtrxthryvtrx.comin𝕏✓ verified

Thryv Therapeutics is a clinical-stage biotech developing precision-medicine treatments for genetic arrhythmia syndromes and acquired cardiometabolic diseases using selective inhibitors of serum glucocorticoid inducible kinase 1 (SGK1).

BiotechDigital HealthMedical Devices

Paul F. Truex(Chairman of the Board & Chief Executive Officer)inDebra Odink(President & Chief Development Officer)inAmy Sehnert(Chief Medical Officer)inMatt Killeen(Chief Business Officer)in

BoardSaumya Das(Chief Scientific Advisor)

Co-investorsLumira VenturesadMare BioInnovationsAmzak HealthCTI Life Sciences Fund L.P.

Abilityability.bio

Ability is a biotechnology company developing highly-selective, immune cell-modulating antibody therapeutics for patients with inflammatory diseases and cancer.

AI & Machine LearningBiotechHealthtechMontreal, CA

Giles Day(Co-founder)in

Co-investorsPage One VenturesAlexandria

Abilityability.aiinJun 2024 · $18M

Ability.ai builds AI agents that automate repetitive, rule-based workflows across business functions like customer support, HR, marketing, sales, finance, and IT, which customers deploy on their own platform called Trinity.

AI & Machine LearningDeveloper ToolsEnterprise SoftwareSaaSSales TechSan Francisco, US

Eugene Vyborov(Founder and CEO)in

Co-investorsSID Venture Partners1991 VenturesAlexandria

CarbiCretecarbicrete.comin𝕏May 2022

CarbiCrete develops a carbon removal technology that enables the production of cement-free concrete by using industrial steel slag and injecting CO2 to provide strength while sequestering carbon.

Circular EconomyCleantechClimate TechConstruction TechNew MaterialsQuebec, CA

Co-investorsAera VCBDC Climate Tech Fund IIInnovative Solutions CanadaNew Climate VenturesSQN Venture Partners, LLCFondaction+1 more

Coveocoveo.comin𝕏

Coveo provides an AI-powered search and generative experience platform that delivers relevant content across search, recommendations, and agentic interfaces for enterprises.

AI & Machine LearningE-commerceEnterprise SoftwareSaaS

Co-investorsIntrepid Growth PartnersMind the Seed - MTS FundBDC Venture Capital

Enerkemenerkem.cominApr 2022 · $255M

Enerkem converts non-recyclable waste and biomass residues into biofuels and chemicals using gasification and syngas conditioning technology.

Circular EconomyCleantechClimate TechEnergyNew MaterialsMontreal, CA

Esteban Chornet(Founder, Professor Emeritus at Université de Sherbrooke)inVincent Chornet(Co-founder)

Co-investorsBraemar Energy VenturesRho VenturesCycle CapitalFondactionMonarch Alternative CapitalThe Westly Group

Epitopeaepitopea.cominOct 2024

Epitopea develops off-the-shelf cancer vaccines targeting aberrantly expressed tumor-specific antigens using its proprietary CryptoMap platform.

AI & Machine LearningBiotechHealthtechMontreal, CA

Claude PerreaultPierre Thibault

Co-investorsAdvent Life SciencesCambridge Innovation CapitalCTI Life Sciences Fund L.P.adMare BioInnovations

Feldan Therapeuticsfeldan.cominSep 2024

Feldan is a clinical-stage biotech company developing intracellular delivery technologies for therapeutic treatment of diseases.

BiotechDeep TechMedical Devices

François-Thomas Michaud(Board Member & Chief Executive Officer)in

Co-investorsGenesys CapitalLinearis VenturesZynext Ventures

Femtumfemtum.cominMar 2026 · $16M

Femtum builds turn-key mid-infrared fiber laser systems that operate without requiring laser experts, serving industrial manufacturers and scientific teams for applications such as selective laser microprocessing and mid-IR spectroscopy.

Deep TechHardwareSemiconductorsQuébec City, CA

Simon Duval(CTO & Co-Founder)inLouis-Rafaël Robichaud(CEO & Co-Founder)inFrançois Courteau(CFO)in

Co-investorsBoreal Venturesi4 CapitalVIGO VenturesBDC Capital CorporationCathay VentureEureka

Flare Systemsflare.ioin𝕏Dec 2024 · $30M

Reduce digital risk and fraud by automating dark, deep and clear web monitoring, to deliver real-time actionable intelligence.

Co-investorsLuge CapitalWhite Star CapitalBase10 PartnersInovia Capital

Fonds de solidarité FTQfondsftq.comin𝕏

Fonds de solidarité FTQ is a Quebec labour-sponsored investment fund offering retirement and savings products (RRSP, TFSA, RRIF) that channel individuals' savings into Quebec businesses.

FintechImpact & Social Good

Co-investorsGrandBanks CapitalDiagramEndeavor CatalystFondactionLa CaisseNAventures

INNO-3Binno-3b.comin𝕏

Inno-3B develops vertical farming equipment that uses automation and digitalization in a closed-loop environment to grow organic greens.

AgTechFoodTechHardware

Martin Brault(Chief Executive Officer, co-founder)inPierre Boulanger(co-founder)in

Co-investorsEcofuel FundDesjardins Capital

Inversagoinversago.comOct 2022 · $35Macquired by Novo Nordisk

Portfolio company acquired by Novo Nordisk for $1.1B USD.

Co-investorsAmorChemGenesys CapitalJDRF T1D FundNew Enterprise Associates (NEA)Tarnagulla VenturesadMare BioInnovations+2 more

Joseph Ribkoffjosephribkoff.comNov 2020

Designs classic and contemporary women's garments.

Stephen Belferin

Co-investorsNovacap

Nestonesto.cainJun 2026 · $300M

Nesto is an online mortgage lending platform in Canada that offers origination, funding, and servicing for residential mortgages with transparent pricing and simplified application processes.

AI & Machine LearningFintechPropTechSaaSCanada, CA

Malik Yacoubi(CEO & Co-Founder)inChase Belair(Co-Founder, Principal Broker)

Co-investorsBreyer CapitalDiagramNAventuresEndeavor CatalystExpedition Growth CapitalFondaction+1 more

Nolknolk.cominOct 2022 · $30M

Nolk acquires and operates direct-to-consumer brands with a focus on sustainability, emphasizing recycled or renewable materials and long-lasting, repairable products.

Circular EconomyDirect to ConsumerE-commerce

Alexandre Renaud(Founder)in

Co-investorsAngels of ManyBoxOne VenturesExport Development Canada (EDC)FondactionPanache Ventures

Oligonoligon.comin𝕏

Oligon Therapeutics develops RNA-based multi-targeting drugs using its SeekR platform, which combines RNA aptamer oligo-binders with siRNA silencers into a single self-delivering molecule for precise targeting of specific cell types, including T-cells and cancer cells.

AI & Machine LearningBiotech

Spyro Mousses(Founder)in

Co-investorsCTI Life Sciences Fund L.P.

Ventusventus.aiinJan 2018 · $100M

Ventus AI is an enterprise automation platform offering AI agents ("AI teammates") that operate inside existing systems—desktop apps, web portals, and legacy software—without API integrations to automate complex business workflows, handling MFA, CAPTCHAs, and phone calls.

AI & Machine LearningEnterprise SoftwareHealthtechCasa Grande

Maran Vedamanikam(CEO and Manager)

Co-investorsSamsung NextAndreessen HorowitzWndrCoAlexandriaBiotechnology Value FundCasdin Capital+5 more

Ventus Therapeuticsventustx.cominApr 2021

Ventus discovers and develops small-molecule medicines using its proprietary ReSOLVE platform, focused on structure-based drug discovery.

AI & Machine LearningBiotechDeep TechHealthtechWaltham, US

Judith Lieberman(Co-Founder)Daniel Koerwer(Executive Officer)inMichael Crackower(Executive Officer)inZachary McNealy(Executive Officer)Marcelo Bigal, M.D., Ph.D.(President and Chief Executive Officer)

BoardJosh Resnick(Director)in

Co-investorsAndreessen HorowitzGV (Google Ventures)RA CapitalSoftBank Vision FundVersant VenturesBiotechnology Value Fund+2 more

WHITE STAR CAPITALwhitestarcapital.comin

Co-investorsCanal VenturesKensington Capital Partners LimitedLa Caisse

Workplace Solutionsjpmorganworkplacesolutions.comin𝕏Apr 2020 · $50M

J.P.

Enterprise SoftwareFintechHR TechSaaS

Co-investorsJ.P. Morgan CazenoveBlumberg CapitalClaridgeInovia CapitalLerer Hippeau

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.